TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2025

Prophylactic Efficacy of CD388, a Novel Drug-Fc Conjugate, in a Human Influenza A/H3N2 Virus Challenge Model: A Randomized, Controlled Phase 2a Study.

Roxana E Rojas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.